Assignee
VENN BIOSCIENCES CORP
US·8 granted patents·17 pending applications·7 citations·filing 2018–2024
Top patents by PatentIndex Score
25 records- 0187US12094575B2Automated detection of boundaries in mass spectrometry dataVENN BIOSCIENCES CORP·Filed 2023·Granted Sep 17, 2024·2 cites·15 claims
- 0285US10837970B2Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoringVENN BIOSCIENCES CORP·Filed 2018·Granted Nov 17, 2020·3 cites·17 claims
- 0381US12456544B2Automated detection of boundaries in mass spectrometry dataVENN BIOSCIENCES CORP·Filed 2024·Granted Oct 28, 2025·0 cites·20 claims
- 0481US11869634B2Automated detection of boundaries in mass spectrometry dataVENN BIOSCIENCES CORP·Filed 2020·Granted Jan 9, 2024·2 cites·21 claims
- 0574US2023324407A1Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoringVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 0672US2024387043A1Diagnosis of colorectal cancer using targeted quantification of peptidesVENN BIOSCIENCES CORP·Filed 2024·Application pending·0 cites
- 0770US2024379228A1Diagnosis of colorectal cancer using targeted quantification of peptidesVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 0867US11624750B2Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoringVENN BIOSCIENCES CORP·Filed 2020·Granted Apr 11, 2023·0 cites·24 claims
- 0965US12287342B2Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)VENN BIOSCIENCES CORP·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 1061US2025111901A1De novo glycopeptide sequencingVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 1158US11774459B2Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)VENN BIOSCIENCES CORP·Filed 2021·Granted Oct 3, 2023·0 cites·21 claims
- 1257US2025149173A1Diagnosis of colorectal cancer using targeted quantification of site-specific protein glycosylationVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 1355US12578346B2Systems and methods for glycopeptide concentration determination, normalized abundance determination, and LC/MS run sample preparationVENN BIOSCIENCES CORP·Filed 2022·Granted Mar 17, 2026·0 cites·9 claims
- 1455US2026004885A1Biomarkers for determining a cancer disease state, response to immuno-oncology, stages of fibrosis in non-alcoholic steatohepatitis, or application of age or sex related biomarker panel for quality controlVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 1554US2025087363A1Predicting sarcoma treatment response using targeted quantification of site-specific protein glycosylationVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 1652US2025189534A1Sample preparation for glycoproteomic analysis that includes diagnosis of diseaseVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 1751US2025232874A1Ai-driven glycoproteomics liquid biopsy in nasopharyngeal carcinomaVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 1850US2024412865A1Biomarkers for diagnosing colorectal cancer or advanced adenomaVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 1948US2023055572A1Biomarkers for diagnosing ovarian cancerVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 2048US2025149121A1Detection of peptide structures for diagnosing and treating sepsis and covidVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 2147US2023065917A1Biomarkers for diagnosing ovarian cancerVENN BIOSCIENCES CORP·Filed 2021·Application pending·0 cites
- 2245US2022310230A1Biomarkers for determining an immuno-onocology responseVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 2344US2023112866A1Biomarkers for clear cell renal cell carcinomaVENN BIOSCIENCES CORP·Filed 2021·Application pending·0 cites
- 2441US2020240996A1Identification and use of biological parameters for diagnosis and treatment monitoringVENN BIOSCIENCES CORP·Filed 2018·Application pending·0 cites
- 2537US2022139499A1Biomarkers for diagnosing ovarian cancerVENN BIOSCIENCES CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VENN BIOSCIENCES CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →